Innovation versus Financialization in the US Pharmaceutical Industry - Elements in Corporate Governance - Tulum, Oner (The Academic-Industry Research Network) - Books - Cambridge University Press - 9781009707985 - November 20, 2025
In case cover and title do not match, the title is correct

Tulum, Oner (The Academic-Industry Research Network)
Innovation versus Financialization in the US Pharmaceutical Industry - Elements in Corporate Governance

Price
R 444
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Nov 11 - 16
Christmas presents can be returned until 31 January
Get notified about new Tulum, Oner (The Academic-Industry Research Network) releases

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Not rated yet

Also available as:

The US government is negotiating with pharmaceutical companies on the price of ten drugs. This Element shows that the companies (a) should have their drug prices regulated, (b) use their profits to distribute cash dividends and stock buybacks; (c) do not rely on investment by shareholders; and (d) benefit from 'collective and cumulative learning.'

Media Books     Paperback Book   (Book with soft cover and glued back)
Released November 20, 2025
ISBN13 9781009707985
Publishers Cambridge University Press
Pages 96
Dimensions 230 × 151 × 8 mm   ·   150 g
Language English  

More from the same publisher

See all of Tulum, Oner (The Academic-Industry Research Network)